Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Ganesh Pawar Article rating: 3.0

The market opened in red on August 3, 2020, overall volumes in futures & options currently stand at 1,64,41,863 crore contracts with a turnover of Rs. 11,37,132.45 crore.

Dilip Buildcon wins HAM project from NHAI in Telangana
Dilip Buildcon wins HAM project from NHAI in Telangana

Dilip Buildcon wins HAM project from NHAI in Telangana

Apurva Joshi Article rating: 3.9

Dilip Buildcon Limited has won a new hybrid annuity model (HAM) project from National Highways Authority of India (NHAI) in the state of Telangana. The project cost is worth Rs 1,140.50 crore.

Jubilant Life Sciences launches Remdesivir injection at Rs 4,700
Jubilant Life Sciences launches Remdesivir injection at Rs 4,700

Jubilant Life Sciences launches Remdesivir injection at Rs 4,700

Nidhi Jani Article rating: 4.6

The company is going to market this product under the brand name ‘Jubi-R’ in India. The company will make the drug available to over 1,000 hospitals providing COVID-19 treatment in India through its distribution network.

D-Street is anticipating recovery
D-Street is anticipating recovery

D-Street is anticipating recovery

Karan Dsij Article rating: 5.0

Yesterday’s session proved to be Black Monday for the Indian markets as both Sensex and Nifty glided below their important psychological level of 37,000 and 11,000, respectively. However, the bulls on D-Street would attempt for revival on Tuesday, aided by the joyful mood amongst the global peers.

Index trend and stocks in action on August 04, 2020
Index trend and stocks in action on August 04, 2020

Index trend and stocks in action on August 04, 2020

Karan Dsij Article rating: 4.0

If Nifty manages to close below the 200-DMA, the next level of meaningful support would be placed at 10,550. Interestingly, the 61.8 per cent retracement of the current upswing is also at 10,860. Stocks in news: Jubilant Life Sciences, Alembic Pharmaceuticals, Infosys.

RSS
First21692170217121722174217621772178Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR